Synergistic Anti-bacterial Effects of Phellinus baumii Ethyl Acetate Extracts and β-Lactam Antimicrobial Agents Against Methicillin-Resistant Staphylococcus aureus
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: The development of new drugs or alternative therapies effective against methicillin-resistant Staphylococcus aureus (MRSA) is of great importance, and various natural anti-MRSA products are good candidates for combination therapies. We evaluated the antibacterial activities of a Phellinus baumii ethyl acetate extract (PBEAE) and its synergistic effects with β-lactams against MRSA. Methods: The broth microdilution method was used to determine the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of the PBEAE. The PBEAE synergistic effects were determined by evaluating the MICs of anti-staphylococcal antibiotic mixtures, with or without PBEAE. Anti-MRSA synergistic bactericidal effects of the PBEAE and β-lactams were assessed by time-killing assay. An ELISA was used to determine the effect of the PBEAE on penicillin binding protein (PBP)2a production. Results: The MICs and MBCs of PBEAE against MRSA were 256-512 and 1,024-2,048 μg/mL, respectively. The PBEAE significantly reduced MICs of all β-lactams tested, including oxacillin, cefazolin, cefepime, and penicillin. However, the PBEAE had little or no effect on the activity of non-β-lactams. Time-killing assays showed that the synergistic effects of two β-lactams (oxacillin and cefazolin) with the PBEAE were bactericidal in nature (Δlog10 colony forming unit/mL at 24 hr: 2.34-2.87 and 2.10-3.04, respectively). The PBEAE induced a dose-dependent decrease in PBP2a production by MRSA, suggesting that the inhibition of PBP2a production was a major synergistic mechanism between the β-lactams and the PBEAE. Conclusions: PBEAE can enhance the efficacy of β-lactams for combined therapy in patients infected with MRSA.
Abstract
Background: The development of new drugs or alternative therapies effective against methicillin-resistant Staphylococcus aureus (MRSA) is of great importance, and various natural anti-MRSA products are good candidates for combination therapies. We evaluated the antibacterial activities of a Phellinus baumii ethyl acetate extract (PBEAE) and its synergistic effects with β-lactams against MRSA. Methods: The broth microdilution method was used to determine the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of the PBEAE. The PBEAE synergistic effects were determined by evaluating the MICs of anti-staphylococcal antibiotic mixtures, with or without PBEAE. Anti-MRSA synergistic bactericidal effects of the PBEAE and β-lactams were assessed by time-killing assay. An ELISA was used to determine the effect of the PBEAE on penicillin binding protein (PBP)2a production. Results: The MICs and MBCs of PBEAE against MRSA were 256-512 and 1,024-2,048 μg/mL, respectively. The PBEAE significantly reduced MICs of all β-lactams tested, including oxacillin, cefazolin, cefepime, and penicillin. However, the PBEAE had little or no effect on the activity of non-β-lactams. Time-killing assays showed that the synergistic effects of two β-lactams (oxacillin and cefazolin) with the PBEAE were bactericidal in nature (Δlog10 colony forming unit/mL at 24 hr: 2.34-2.87 and 2.10-3.04, respectively). The PBEAE induced a dose-dependent decrease in PBP2a production by MRSA, suggesting that the inhibition of PBP2a production was a major synergistic mechanism between the β-lactams and the PBEAE. Conclusions: PBEAE can enhance the efficacy of β-lactams for combined therapy in patients infected with MRSA.
참고문헌 (27)
- "“Celbenin”-resistant Staphylococci", Br Med J, 1, pp.113~114 (1961)
- Rosenthal VD, "International Nosocomial Infection Control Consortorium (INICC) report, data summary for 2003-2008, issued June 2009", Am J Infect Control, 38, pp.95~104 (2010)
- Chambers HF, "The changing epidemiology of Staphylococcus aureus?", Emerg Infect Dis, 7, pp.178~182 (2001)
- 이경원, "Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009", Yonsei Medical Journal, 52(5), pp.793~802 (2011), 연세대학교의과대학
- Courvalin P, "Vancomycin resistance in gram-positive cocci", Clin Infect Dis, 42(S1), pp.S25~S34 (2006)
- Friedman L, "Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus", Antimicrob Agents Chemother, 50, pp.2137~2145 (2006)
- Tsiodras S, "Linezolid resistance in a clinical isolate of Staphylococcus aureus", Lancet, 358, pp.207~208 (2001)
- Mahady GB, "Medicinal plants for the prevention and treatment of bacterial infections", Curr Pharm Des, 11, pp.2405~2427 (2005)
- Gibbons S, "Anti-staphylococcal plant natural products", Nat Prod Rep, 21, pp.263~277 (2004)
- Hemaiswarya S, "Synergism between natural products and antibiotics against infectious diseases", Phytomedicine, 15, pp.639~652 (2008)
- Shimizu M, "Marked potentiation of activity of β-lactams against methicillin-resistant Staphylococcus aureus by corilagin", Antimicrob Agents Chemother, 45, pp.3198~3201 (2001)
- Shiota S, "Mechanisms of action of coriligan and tellimagrandin I that remarkably potentiate the activity of β-lactams against methicillin-resistant Staphylococcus aureus", Microbiol Immunol, 48, pp.67~73 (2004)
- Hwang HJ, "Morphological and rheological properties of the three different species of blasidiomycetes Phellinus in submerged cultures", J Appl Microbiol, 96, pp.1296~1305 (2004)
- Jung-Ran Noh, "A Phellinus baumii Extract Reduces Obesity in High-Fat Diet-Fed Mice and Absorption of Triglyceride in Lipid-Loaded Mice", Journal of Medicinal Food, 14(3), pp.209~218 (2011), 한국식품영양과학회
- Lee IK, "Styrilpyrones from the medicinal fungus Phelinus baumii and their antioxidant properties", Bioorg Med Chem Lett, 20, pp.5459~5461 (2010)
- Hwang HJ, "Hypoglycemic effect of crude exopolysaccharides produced by a medicinal mushroom Phellinus baumii in streptozotocin-induced diabetic rats", Life Sci, 76, pp.3069~3080 (2005)
- Kamruzzaman SM, "Antiplatelet activity of Phellinus baumii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β3 and MAP kinase", Phytother Res, 25, pp.1596~1603 (2011)
- Yayeh T, "Phellinus baumii ethyl acetate extract inhibits lipopolysaccharide-induced iNOS, COX-2, and proinflammatory cytokine expression in RAW264.7 cells", J Nat Med, 66, pp.49~54 (2012)
- Clinical Laboratory Standards Institute, "Methods for determining bactericidal activity antimicrobial agents", CLSI, ~ (1999)
- Clinical Laboratory Standards Institute, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically", CLSI, ~ (2012)
- Chin JN, "Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa", J Antimicrob Chemother, 61, pp.365~370 (2008)
- Hur JM, "Antibacterial effect of Phellinus linteus against methicillin-resistant Staphylococcus aureus", Fitoterapia, 75, pp.603~605 (2004)
- Stermitz FR, "Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus", Planta Med, 68, pp.1140~1141 (2002)
- Brown DF, "Intrinsic resistance to beta-lactam antibiotics in Staphylococcus aureus", FEBS Lett, 122, pp.275~278 (1980)
- Hartman BJ, "Low-affinity penicillin-binding protein associated with β-lactam resistance Staphylococcus aureus", J Bacteriol, 158, pp.513~516 (1984)
- Nicolson K, "Potentiation of methicillin activity against methicillin-resistant Staphylococcus aureus by diterpenes", FEMS Microbiol Lett, 179, pp.233~239 (1999)
- Wu CS, "Phenolic compounds with NF-κB inhibitory effects from the fungus Phellinus baumii", Bioorg Med ChemLett, 21, pp.3261~3267 (2011)